Perlmutter Cancer Center - NYU Langone Health — New York, New York

Perlmutter Cancer Center - NYU Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center - NYU Langone Health has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC.

Sponsors: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Arsenal Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center - NYU Langone Health?

Perlmutter Cancer Center - NYU Langone Health has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center - NYU Langone Health conducted?

Perlmutter Cancer Center - NYU Langone Health has 3 clinical trials on record, with 3 currently active. Their work covers Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC.

Is Perlmutter Cancer Center - NYU Langone Health accredited by Crixeo Health?

Perlmutter Cancer Center - NYU Langone Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center - NYU Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.